Literature DB >> 10097887

Imaging developing brain infarction.

A E Baird1, S Warach.   

Abstract

Continued advances in neuroimaging technology have made it practical to image multiple aspects of evolving brain infarction during the potential window period of therapeutic opportunity in stroke. Recent methodologic developments include computed tomography angiography and perfusion, and the description of quantitative parameters for magnetic resonance blood oxygen level-dependent perfusion imaging. In pathophysiologic studies, metabolism and function in the ischemic focus and the peri-infarct tissue have been further characterized. Clinical studies have focused on the applications of computed tomography and magnetic resonance imaging for prethrombolysis patient selection. These methods have an important role in the evaluation and development of new pharmaceutical agents and will be increasingly used in clinical practice as new therapies become available.

Entities:  

Mesh:

Year:  1999        PMID: 10097887     DOI: 10.1097/00019052-199902000-00011

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

Review 1.  [Diagnosis of stroke--an update].

Authors:  Franz T Aichner
Journal:  Wien Med Wochenschr       Date:  2003

2.  Direct visualization of mouse brain oxygen distribution by electron paramagnetic resonance imaging: application to focal cerebral ischemia.

Authors:  Jiangang Shen; Rohit Sood; John Weaver; Graham S Timmins; Aaron Schnell; Minoru Miyake; Joseph P Y Kao; Gerald M Rosen; Ke Jian Liu
Journal:  J Cereb Blood Flow Metab       Date:  2009-07-15       Impact factor: 6.200

3.  Stroke penumbra defined by an MRI-based oxygen challenge technique: 1. Validation using [14C]2-deoxyglucose autoradiography.

Authors:  Craig A Robertson; Christopher McCabe; Lindsay Gallagher; Maria del Rosario Lopez-Gonzalez; William M Holmes; Barrie Condon; Keith W Muir; Celestine Santosh; I Mhairi Macrae
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.